Filing Details

Accession Number:
0001127602-17-010410
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-06 13:57:47
Reporting Period:
2017-03-02
Filing Date:
2017-03-06
Accepted Time:
2017-03-06 13:57:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1613103 Medtronic Plc MDT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1610035 Hooman Hakami 710 Medtronic Pkwy Ms Lc300
Minneapolis MN 55432
Evp & Group President Diabetes No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2017-03-02 14,871 $62.76 73,800 No 4 M Direct
Ordinary Shares Acquisiton 2017-03-02 797 $62.76 74,597 No 4 M Direct
Ordinary Shares Acquisiton 2017-03-02 36,648 $62.76 111,245 No 4 M Direct
Ordinary Shares Disposition 2017-03-02 52,316 $82.33 58,929 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2017-03-02 14,871 $0.00 14,871 $62.76
Ordinary Shares Stock Option (Right to Buy) Disposition 2017-03-02 797 $0.00 797 $62.76
Ordinary Shares Stock Option (Right to Buy) Disposition 2017-03-02 36,648 $0.00 36,648 $62.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
89,762 2024-07-28 No 4 M Direct
88,965 2024-07-28 No 4 M Direct
52,317 2024-07-28 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.30 to $82.41, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. This balance increased by 627 shares due to exempt transactions such as dividend reinvestment.
  3. This option to purchase 29,743 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 29,743 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
  4. This option to purchase 1,594 ordinary shares of New Medtronic for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
  5. This option to purchase 73,296 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 73,296 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.